LINC01091

Across TCGA pan-cancer cohorts, LINC01091 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01091 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher LINC01091 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01091 expression acts as an unfavorable survival marker, although some lineages such as PAAD and MESO show a favorable association.

LGG, PAAD, and KIRP are the cancer types where LINC01091 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Median	All	0.660	0.806	<.001	51	view →
PAAD	DFS	Tertile	All	0.425	0.172	.001	42	view →
KIRP	OS	Median	All	0.894	0.968	.007	39	view →
MESO	OS	Tertile	III,IV	0.741	0.425	<.001	36	view →
LUSC	DFS	Median	All	0.277	0.457	.002	33	view →
OV	OS	Quartile	IV	0.524	0.207	.004	30	view →
HNSC	DFS	Tertile	IV	0.695	0.479	.004	25	view →
UVM	OS	Quartile	All	0.739	0.363	.005	17	view →
ACC	OS	Median	II,III,IV	0.301	0.734	.004	15	view →
CESC	DFS	Median	All	0.664	0.802	.004	14	view →
SKCM	DFS	Median	II,III,IV	0.387	0.169	.009	10	view →
COAD	DFS	Median	III,IV	0.471	0.653	.019	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01091–LGG (DFS)

Open the LGG breakdown →